Vanda Pharmaceuticals (Nasdaq: VNDA) announced the sale of 5,000,000 shares of its common stock in an underwritten public offering at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE